Enterprise deals stalling on HIPAA & BAA
Health systems and large payers run a security review before signing. An unanswered BAA or HIPAA gap parks the deal in IT and procurement for quarters — often indefinitely.
HealthTech revenue & compliance diagnostic
Find the HIPAA gap stalling health-system deals.
HIPAA and BAA gaps parking enterprise deals, pricing below the healthcare value band and pilots that never become contracts: located and priced in a written report, reviewed and signed by the founder.
7 questions · 3 minutes · no email needed to see your grade
Reviewed and signed by Waleed Alvi, PMP® · RMP®
No calls, written report
UK company 17258465
Revenue Integrity BriefIllustrative sample
Two enterprise deals stalled on HIPAA.
- Compliance verdictPursue HITRUST e1 now
- Enterprise pipeline blocked~$540K
- Pricing gap vs healthcare band~35% below
- Pilot-to-contract rate28% (benchmark 40%+)
Where revenue leaks
The leaks we find most often in HealthTech companies.
Priced below the healthcare value band
Digital-health pricing often sits like horizontal SaaS, while healthcare buyers carry budget, regulatory weight, and clinical risk that justify materially higher pricing — typically 30-50% above current rates.
Pilots that never become rollouts
Pilot-to-contract conversion below 40% is the norm, yet most HealthTech companies accept it. Every stalled pilot is ARR that entered the funnel and never reached value — revenue lost, not deferred.
How it works
Three steps. No meetings.
Every tier follows the same path. Only the depth of the diagnosis changes with the price.
Pick your diagnostic
Choose the tier that fits your ARR, or take the free grade first and let it point you to one.
2 minutesAnswer the intake
18 questions on pricing, retention and pipeline. Anything you don't have is flagged in the report, never guessed.
About 15 minutesGet your written report
Every leak located, priced and ranked, with the fixes in order, reviewed and signed by the founder.
18–24 hours · Starter 48–72Try it on your numbers
Estimate your leak in 30 seconds.
Four inputs, one directional estimate from published benchmarks. It is a preview, not the diagnostic.
50/100
Estimated annual recoverable
$0
Directional only. The diagnostic replaces every estimate with a figure from your own numbers.
What the diagnostic reads first
Five frameworks built for the questions your enterprise pipeline actually asks.
F1
Pricing & value-band fit
How far below the healthcare value band are you priced — and which tier or module structure closes the gap?
F2
Retention & NRR
Where is NRR leaking — involuntary churn, failed renewal, or flat expansion — and what is the dollar repair?
F3
Pilot-to-contract activation
What share of pilots convert to contracts, how long does it take, and what is the revenue lost in the gap?
F4
HIPAA compliance readiness
Which specific compliance gap is blocking which enterprise deal — and what does it take to clear it?
F5
GTM & sales-cycle efficiency
Is your sales cycle running above the digital-health median — and how much of the excess traces to compliance friction?
These five are read first. Each tier below states exactly how far the diagnosis goes beyond them.
Pricing
One-time price. No retainer, no calls.
Pick the tier that matches your ARR. Every diagnostic is reviewed and signed by the founder and delivered in writing.
The 3 most painful HealthTech frameworks on your real numbers — plus the HIPAA / BAA compliance readiness map. Sharp first read before the full diagnostic. vs $15K–$50K specialist consultants charge for the HIPAA / HITRUST scoping alone.
What you get
- 3 deepest frameworks — all 18 scored
- Your total revenue-leak figure
- Compliance readiness map (HIPAA & SOC 2)
- HITRUST e1-vs-r2 path guidance
- Board-grade PDF in 48-72 hours
Seed to Series A. The full board-grade diagnosis — compliance readiness map, pricing verdict, activation plan, dollar-precise at your stage. About 0.5% of the ~$675K–$1.35M a sub-$5M-ARR HealthTech company is typically bleeding.
1% gain ≈ up to $10K/yr at your scale
Everything in Starter, made complete
- All 18 frameworks, fully scored
- Every leak quantified in dollars
- Full compliance readiness map
- Your top 5 fixes, prioritized
- 90-day roadmap + risk heatmap
- Board-grade PDF, ⚡ in 18–24 hours (VIP)
Seed to Series A. The full board-grade diagnosis — compliance readiness map, pricing verdict, activation plan, dollar-precise at your stage. About 0.5% of the ~$675K–$1.35M a sub-$5M-ARR HealthTech company is typically bleeding.
1% gain ≈ $10K–$30K/yr at your scale
Everything in Starter, made complete
- All 18 frameworks, fully scored
- Every leak quantified in dollars
- Full compliance readiness map
- Your top 5 fixes, prioritized
- 90-day roadmap + risk heatmap
- Board-grade PDF, ⚡ in 18–24 hours (VIP)
Series A to B. The full diagnosis at the depth a scaling digital-health team with a growing enterprise pipeline needs. About 0.5% of the ~$1.35M–$2.25M a $5M–$25M-ARR HealthTech company is typically bleeding.
1% gain ≈ $30K–$150K/yr at your scale
Everything in Founder, plus
- Extended framework depth per finding
- Competitive landscape context
- Revenue recovered, modeled per fix
- Full fix backlog, ranked by impact
- 30-day written Q&A window
- Board-grade PDF, ⚡ in 18–24 hours (VIP)
Series B+. Everything in Growth, at the depth a mature digital-health org with a complex enterprise pipeline needs. About 0.5% of the ~$3M+ a $25M–$50M-ARR HealthTech company is typically bleeding.
1% gain ≈ $150K–$500K/yr at your scale
Everything in Growth, plus
- Implementation guidance for your top 3 fixes
- Scenario-based revenue modelling
- Senior written strategic debrief
- Priority delivery
- Board-grade PDF, ⚡ in 18–24 hours (VIP)
Card, Apple Pay or Google Pay. Bank transfer (Wise) on Founder, Growth and Scale.Useful, or we rework it free. All sales final.Not sure which? Take the free grade first
Sample report
What you actually receive.
- Cited benchmarks
- Dollar-quantified findings
- Compliance readiness map
- HITRUST path guidance
Format
A board-grade PDF: approximately 22 pages for the Founder tier (5 for the Starter). Cover, exec summary, 18-framework scorecard, dollar-quantified findings, compliance readiness map, HITRUST path guidance, 90-day priority roadmap.
Who runs your diagnostic
Reviewed and signed by the founder.
PMP®- and RMP®-certified senior planning engineer (BEng Hons). Every diagnostic is personally run, reviewed and signed by me — no outsourced analysts, no call-booking funnel. The methodology is public: judge the teardowns before you spend a dollar.
Judge the method before you buy. Public teardowns:
Waleed AlviFounder, Intake Review · PMP® · RMP® · BEng (Hons)
- CompanyIntake Review Ltd · UK Companies House No. 17258465
- Registered office71-75 Shelton Street, London WC2H 9JQ
- How we workWritten reports only. A clarifying question comes by email, never a meeting.
- Contacthello@intakereview4500.com
- ProfileLinkedIn
Useful, or we rework it free.
If a finding doesn't hold up, a number needs sharpening or an input is missing, we rework the diagnostic at no charge until you can act on it. All sales are final; the rework is the guarantee.
Questions
What founders ask before buying.
Really no calls?
Really. Everything is async. You fill the intake, we deliver a written report. Your time stays yours. The only exception: if a finding needs a clarifying question, we ask it by email — never a meeting.
What if my compliance data is incomplete?
We infer from your stage, ARR, headcount, and stated compliance posture using cited benchmarks. Every assumption is flagged. A complete, useful diagnostic still ships — and we tell you exactly which 3 numbers to capture to upgrade it.
Is $4,500 worth it?
The typical HealthTech diagnostic surfaces six figures in recoverable revenue and pipeline — including enterprise deals blocked by compliance gaps that can be cleared for well under $70K. We sit well below the cheapest boutique alternative, and the compliance readiness map alone typically surfaces more dollar value than the fee. We don't stop at delivered: if it isn't useful, we rework it free until it is.
What format is the report?
A board-grade PDF: approximately 22 pages for the Founder tier (5 for the Starter). Cover, exec summary, 18-framework scorecard, dollar-quantified findings, compliance readiness map, HITRUST path guidance, 90-day priority roadmap.
How do you handle confidentiality?
Standard mutual NDA on request, sent before intake. All anonymized analysis only — no name, logo, or identifying figures leave our system. UK Ltd #17258465 means real legal accountability.
Who is this for?
B2B digital-health founders, CEOs, CROs, and Heads of Growth at $750K-$30M ARR, 8-200 staff, from post-seed through Series B — selling to health systems, payers, clinics, or pharma. If you're earlier, take the free Revenue Leak Snapshot first.
Know which gap is parking which deal.
Start with the free grade. When you're ready, the diagnostic puts a dollar figure and a fix on every leak.